CARECLOUD INC (CCLD) Stock Fundamental Analysis
NASDAQ:CCLD - Nasdaq - US14167R1005 - Common Stock - Currency: USD
CCLD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 39 industry peers in the Health Care Technology industry. While CCLD seems to be doing ok healthwise, there are quite some concerns on its profitability. CCLD has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
CCLD had negative earnings in the past year.
In the past year CCLD had a positive cash flow from operations.
In the past 5 years CCLD always reported negative net income.
CCLD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CCLD's Return On Assets of -71.82% is on the low side compared to the rest of the industry. CCLD is outperformed by 72.97% of its industry peers.
The Return On Equity of CCLD (-109.17%) is worse than 62.16% of its industry peers.
CCLD has a Return On Invested Capital of 8.44%. This is amongst the best in the industry. CCLD outperforms 94.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -71.82% | ||
| ROE | -109.17% | ||
| ROIC | 8.44% |
ROA(3y)-32.68%
ROA(5y)-25.49%
ROE(3y)-58.54%
ROE(5y)-43.02%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Operating Margin value of 4.69%, CCLD belongs to the best of the industry, outperforming 83.78% of the companies in the same industry.
CCLD has a worse Gross Margin (43.42%) than 64.86% of its industry peers.
In the last couple of years the Gross Margin of CCLD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.69% | ||
| PM (TTM) | N/A | ||
| GM | 43.42% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y0.66%
2. Health
2.1 Basic Checks
CCLD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CCLD has more shares outstanding than it did 1 year ago.
CCLD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CCLD is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.88 indicates that CCLD is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.88, CCLD is in the better half of the industry, outperforming 62.16% of the companies in the same industry.
CCLD has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
CCLD has a Debt to FCF ratio of 0.05. This is amongst the best in the industry. CCLD outperforms 89.19% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CCLD is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, CCLD is in the better half of the industry, outperforming 70.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 1.88 |
ROIC/WACC0.8
WACC10.49%
2.3 Liquidity
CCLD has a Current Ratio of 1.03. This is a normal value and indicates that CCLD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.03, CCLD is doing worse than 67.57% of the companies in the same industry.
CCLD has a Quick Ratio of 1.01. This is a normal value and indicates that CCLD is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.01, CCLD is not doing good in the industry: 67.57% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.03 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 57.36% over the past year.
CCLD shows a decrease in Revenue. In the last year, the revenue decreased by -8.38%.
Measured over the past years, CCLD shows a quite strong growth in Revenue. The Revenue has been growing by 18.31% on average per year.
EPS 1Y (TTM)57.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.48%
Revenue 1Y (TTM)-8.38%
Revenue growth 3Y3.66%
Revenue growth 5Y18.31%
Sales Q2Q%-2.51%
3.2 Future
The Earnings Per Share is expected to grow by 22.66% on average over the next years. This is a very strong growth
CCLD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.96% yearly.
EPS Next Y79.41%
EPS Next 2Y36.09%
EPS Next 3Y22.66%
EPS Next 5YN/A
Revenue Next Year-7.47%
Revenue Next 2Y-3.1%
Revenue Next 3Y-0.96%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CCLD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CCLD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
CCLD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CCLD is cheaper than 100.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCLD indicates a rather cheap valuation: CCLD is cheaper than 97.30% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.95 | ||
| EV/EBITDA | 2.71 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CCLD's earnings are expected to grow with 22.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.09%
EPS Next 3Y22.66%
5. Dividend
5.1 Amount
CCLD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.57
-0.19 (-5.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.24%
Inst Owner ChangeN/A
Ins Owners37.42%
Ins Owner Change6.3%
Market Cap57.98M
Analysts82
Price Target5.34 (49.58%)
Short Float %1.55%
Short Ratio0.82
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DP-5.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-143.02%
Min EPS beat(2)-357.52%
Max EPS beat(2)71.48%
EPS beat(4)2
Avg EPS beat(4)-48.69%
Min EPS beat(4)-357.52%
Max EPS beat(4)93.25%
EPS beat(8)4
Avg EPS beat(8)-29.99%
EPS beat(12)8
Avg EPS beat(12)-3.98%
EPS beat(16)12
Avg EPS beat(16)0.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.94%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)-1.89%
Revenue beat(4)0
Avg Revenue beat(4)-3.98%
Min Revenue beat(4)-9.77%
Max Revenue beat(4)-1.89%
Revenue beat(8)0
Avg Revenue beat(8)-4.8%
Revenue beat(12)1
Avg Revenue beat(12)-3.54%
Revenue beat(16)3
Avg Revenue beat(16)-2.31%
PT rev (1m)9.17%
PT rev (3m)9.17%
EPS NQ rev (1m)7.2%
EPS NQ rev (3m)7.2%
EPS NY rev (1m)8.99%
EPS NY rev (3m)35.58%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.48%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.52 | ||
| P/FCF | 4.95 | ||
| P/OCF | 3.03 | ||
| P/B | 1.25 | ||
| P/tB | 8.03 | ||
| EV/EBITDA | 2.71 |
EPS(TTM)-0.55
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)0.72
FCFY20.21%
OCF(TTM)1.18
OCFY33.04%
SpS6.84
BVpS2.86
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -71.82% | ||
| ROE | -109.17% | ||
| ROCE | 10.69% | ||
| ROIC | 8.44% | ||
| ROICexc | 8.95% | ||
| ROICexgc | 61.55% | ||
| OM | 4.69% | ||
| PM (TTM) | N/A | ||
| GM | 43.42% | ||
| FCFM | 10.55% |
ROA(3y)-32.68%
ROA(5y)-25.49%
ROE(3y)-58.54%
ROE(5y)-43.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y0.66%
F-Score6
Asset Turnover1.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 48.43% | ||
| Cap/Sales | 6.7% | ||
| Interest Coverage | 5.55 | ||
| Cash Conversion | 93.12% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.03 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 1.88 |
F-Score6
WACC10.49%
ROIC/WACC0.8
Cap/Depr(3y)85.6%
Cap/Depr(5y)83.34%
Cap/Sales(3y)8.65%
Cap/Sales(5y)7.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.48%
EPS Next Y79.41%
EPS Next 2Y36.09%
EPS Next 3Y22.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.38%
Revenue growth 3Y3.66%
Revenue growth 5Y18.31%
Sales Q2Q%-2.51%
Revenue Next Year-7.47%
Revenue Next 2Y-3.1%
Revenue Next 3Y-0.96%
Revenue Next 5YN/A
EBIT growth 1Y349.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year612.5%
EBIT Next 3Y103.51%
EBIT Next 5YN/A
FCF growth 1Y33%
FCF growth 3YN/A
FCF growth 5Y-7.81%
OCF growth 1Y-9.74%
OCF growth 3YN/A
OCF growth 5Y17.82%